Get startedLog in
    Picture of Shenzhen Hepalink Pharmaceutical Co logo

    9989 — Shenzhen Hepalink Pharmaceutical Co News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Shenzhen Hepalink Pharmaceutical Group Posts QTRLY Net Profit Attributable Of RMB143.5 Million

    Picture of Shenzhen Hepalink Pharmaceutical Co logoShenzhen Hepalink Pharmaceutical Co
    28/04/2021 16:07
    April 28 (Reuters) - Shenzhen Hepalink Pharmaceutical Group
Co Ltd  002399.SZ :
    * QTRLY NET PROFIT ATTRIBUTABLE RMB143.5 MILLION VERSUS
RMB255.3
MILLION
    * QTRLY OPERATING REVENUE RMB1.27 BILLION VERSUS RMB1.40
BILLION

Source text for Eikon:  urn:newsml:reuters.com:*:nHKS8YSDfT
Further company coverage:  002399.SZ 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Shenzhen Hepalink Pharmaceutical Co

    See all news